Stool test for gut inflammation in Hirschsprung disease
Part of Digestive system, Genetic & congenital clinical trials.
This study is looking at a protein called calprotectin in the stool of babies and young children with Hirschsprung's disease. The goal is to see if it can help detect a serious gut inflammation called enterocolitis earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be under 5 years old.
- Your child must have Hirschsprung's disease, confirmed by a biopsy.
- Your child's Hirschsprung's disease cannot involve the entire colon or the small bowel.
- Your child must not have inflammatory bowel disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects leftover intestine tissue from children having bowel surgery to help develop future treatments using a child's own cells. It aims to find better ways to repair the bowel without needing donor tissue.
This study compares a new, non-invasive device to the current standard test (which is more invasive) for measuring how well the large bowel works in children. It may help diagnose or monitor bowel function without the need for a more uncomfortable procedure.
This study tests whether physiotherapy (special exercises) can help children who still have bowel problems after surgery for Hirschsprung's disease. The goal is to see if physiotherapy improves their quality of life and bowel function.
This trial tests a new stool test to measure calprotectin levels, which could help doctors tell the difference between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). If you have symptoms like stomach pain, diarrhea, or weight loss and are about to have a colonoscopy, you may be able to join.
This study looks at a protein in stool called calprotectin, which can show inflammation in the gut. It compares levels in people infected with certain parasites, those with gut symptoms but no parasites, and healthy volunteers to see if it helps identify infection-related inflammation.
This study looks at a substance called calprotectin, which is a marker of inflammation in the gut. It aims to understand gut health in very young babies who have serious heart conditions and need treatment soon after birth.
Hear when a new Hirschsprung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.